| Literature DB >> 30936763 |
Marthe R Onrust1, Stephan Tfm Frequin2.
Abstract
BACKGROUND: A few young patients were brought in with subacute combined spinal cord degeneration at the Department of Neurology in our hospital. They all have used laughing gas for recreational purposes. CASE: A 30-year-old woman, known with alcohol abuse, was presented to our Department of Neurology for having paresthesia and unstable movements of arms, legs, and trunk for 9 days. She has used 50 laughing gas patterns per day. The diagnosis of laughing gas-induced combined spinal cord degeneration was evident by the low count of vitamin B12 combined with lesions shown on magnetic resonance imaging (MRI). Abstaining from the laughing gas, weekly intramuscular injections of hydroxocobalamin and revalidation, she was fully recovered in 8 weeks.Entities:
Keywords: Cobalamin; combined spinal cord degeneration; inverted V-sign; laughing gas; nitrous oxide
Year: 2019 PMID: 30936763 PMCID: PMC6435870 DOI: 10.1177/1179573519838277
Source DB: PubMed Journal: J Cent Nerv Syst Dis ISSN: 1179-5735
Figure 1.The role of vitamin B12 and laughing gas in the homocysteine/methionine pathway.[4]
Figure 2.(A) T2-weighted sagittal image of the cervical spinal cord. From C2 to C7, a hyperintensity is shown. (B) T2-weighted axial image of cervical spinal cord. An “inverted V-sign” is shown.
Laboratory findings.
| Reference | ||
|---|---|---|
| Hemoglobin | 8.3 | 7.0-9.3 mmol/L |
| Hematocrit | 0.40 | 0.32-0.44 L/L |
| MCV | 96 | 82-98 fL |
| Vitamin B12 | 116 | 140-490 pmol/L |
| Folic acid | 14.8 | 8.8-60.8 nmol/L |
| Homocysteine | 48.3 | <11.4 μmol/L |
| Methyl malonic acid | 1.43 | 0.0-0.35 μmol/L |
Abbreviation: MCV, mean corpuscular volume.
Laughing gas–induced myelopathy, case studies.
| Reference | Gender, age | Neurologic examination | MRI | Treatment: intramuscular hydroxocobalamin injections |
|---|---|---|---|---|
| Massey et al[ | Male, 36 | Posterior funiculus disorder; corticospinal tract disorder | T2 hyperintensity C1-T11 | 6× 1000 μg/day for 2 weeks, then 1000 μg/week + physiotherapy |
| Hsu et al[ | Male, 19 | Posterior funiculus disorder; corticospinal tract disorder | T2 hyperintensity cervical in dorsal and lateral column | 1000 μg/day for 5 days, then 2 months 1000 μg/week |
| Yuan et al[ | Female, 20 | Posterior funiculus disorder; corticospinal tract disorder | T2 hyperintensity C1-Th12, inverted V-sign | 1000 μg/day for 3 months |
| Chen et al[ | Female, 20 | Posterior funiculus disorder; corticospinal tract disorder | T2 hyperintensity C1-C6 dorsal column | 2000 μg/day first 3 days, then orally |
| Mancke et al[ | Male, 35 | Posterior funiculus disorder; corticospinal tract disorder | T2 hyperintensity posterior column, inverted V-sign | 1000 μg/day + methionine for 7 days, then orally 400 μg/day for 6 months |
| Morris et al[ | Male, 22 | Posterior funiculus disorder; corticospinal tract disorder | No lesions | 1000 μg for 7 days, afterwards 1000 μg/week orally + multivitamins daily |
| Thompson et al[ | Male, 22 | Posterior funiculus disorder; corticospinal tract disorder | No lesions | IVIG 0.4 g/kg/day for 5 days, then 1000 μg/day |
| Male, 27 | Posterior funiculus disorder; corticospinal tract disorder | Not conducted | IVIG 0.4 g/kg/day for 5 days, then 1000 μg/day | |
| Female, 23 | Posterior funiculus disorder | Not conducted | 1000 μg | |
| Rheinboldt et al[ | Male, 35 | Posterior funiculus disorder; corticospinal tract disorder | T2 hyperintensity C2-C3 and C6-C7 | One injection of 1000 μg; supportive care |
| Cheng et al[ | Female, 22 | Posterior funiculus disorder; corticospinal tract disorder | T2 hyperintensity dorsal column C2-C4 | 1000 μg/day + physiotherapy |
| Wijesekera et al[ | Female, 19 | Posterior funiculus disorder; corticospinal tract disorder | T2 hyperintensity central and dorsal column C2-Th11 | 6× 1000 μg injections, then symptomatic therapy |
| Singer et al[ | Female, 27 | Posterior funiculus disorder; corticospinal tract disorder | T2 hyperintensity dorsal cervical column | Monthly 1000μ μg injections for 10 months |
| Butzkueven et al[ | Male, 23 | Posterior funiculus disorder; corticospinal tract disorder | T2 hyperintensity dorsal cervical column | 1000 μg/day and methionine orally 1 g/day for 3 months |
Abbreviations: IVIG, intravenous immunoglobulin; MRI, magnetic resonance imaging.